kr54.80
2.14% yesterday
Stockholm, Jan 05, 12:59 pm CET
ISIN
SE0009806284
Symbol
PAX

Paxman Stock price

kr54.80
-2.20 3.86% 1M
-24.40 30.81% 6M
-1.40 2.49% YTD
-15.00 21.49% 1Y
+11.30 25.98% 3Y
+27.80 102.96% 5Y
+43.10 368.38% 10Y
+43.10 368.38% 20Y
Stockholm, Closing price Mon, Jan 05 2026
-1.20 2.14%
ISIN
SE0009806284
Symbol
PAX

Key metrics

Basic
Market capitalization
kr1.3b
Enterprise Value
kr1.2b
Net debt
positive
Cash
kr129.5m
Shares outstanding
23.3m
Valuation (TTM | estimate)
P/E
249.1 | 68.7
P/S
4.4 | 4.0
EV/Sales
4.0 | 3.6
EV/FCF
negative
P/B
3.1
Financial Health
Equity Ratio
72.2%
Return on Equity
24.5%
ROCE
3.4%
ROIC
3.6%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
kr295.1m | kr325.7m
EBITDA
kr34.6m | kr32.3m
EBIT
kr14.7m | kr8.1m
Net Income
kr4.9m | kr18.6m
Free Cash Flow
kr-7.0m
Growth (TTM | estimate)
Revenue
21.7% | 28.7%
EBITDA
-27.5% | -35.0%
EBIT
-52.6% | -75.9%
Net Income
-81.3% | -53.8%
Free Cash Flow
-142.5%
Margin (TTM | estimate)
Gross
67.3%
EBITDA
11.7% | 9.9%
EBIT
5.0%
Net
1.7% | 5.7%
Free Cash Flow
-2.4%
More
EPS
kr0.2
FCF per Share
kr-0.3
Short interest
-
Employees
105
Rev per Employee
kr2.4m
Show more

Is Paxman a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,084 stocks worldwide.

Financial data from Paxman

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
295 295
22% 22%
100%
- Direct Costs 96 96
33% 33%
33%
199 199
17% 17%
67%
- Selling and Administrative Expenses 92 92
41% 41%
31%
- Research and Development Expense - -
-
-
35 35
28% 28%
12%
- Depreciation and Amortization 20 20
19% 19%
7%
EBIT (Operating Income) EBIT 15 15
53% 53%
5%
Net Profit 4.92 4.92
81% 81%
2%

In millions SEK.

Don't miss a Thing! We will send you all news about Paxman directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Paxman AB engages in the research and development of scalp cooling system. It focuses on its product, PAXMAN Scalp Cooling System, which is used to minimize hair loss in connection with chemotherapy treatment. The company was founded by Glenn Ann Paxman in 1996 and is headquartered in Karlshamn, Sweden.

Head office Sweden
CEO Richard Paxman
Employees 105
Founded 2016
Website www.paxman.se

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today